Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Wnt antagonists and their use in the diagnosis and treatment of Wnt-mediated disorders

Wnt antagonists and their use in the diagnosis and treatment of Wnt-mediated disorders

US Patent 7947277 · Granted May 24, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-B7-H4 antibodies and immunoconjugates2025
Anti-B7-H4 antibodies and immunoconjugates2024
PepCon proteomics standards and methods of use2024
PepCon proteomics standards and methods of use2022
Anti-B7-H4 antibodies and immunoconjugates2022
Anti-B7-H4 antibodies and immunoconjugates2022
Anti-transferrin receptor antibodies and methods of use2021
Biodegradable surfactants and related compositions, methods and systems2021
Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of u2021
Anti-Ly6E antibodies and methods of use2021
Host cell comprising nucleic acids encoding bispecific antibodies binding to bet2021
Anti-transferrin receptor antibodies and methods of use2020